by U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Division of Epidemiology and Prevention Research in Rockville, MD (5600 Fishers Lane, Rockville 20857) .
Written in English
|Other titles||Cost benefit, cost effectiveness research of drug abuse prevention.|
|Statement||editors, William J. Bukoski, Richard I. Evans.|
|Series||NIDA research monograph -- 176., NIH publication -- no. 98-4021.|
|Contributions||Bukoski, William J., Evans, Richard I. 1922-, National Institute on Drug Abuse. Division of Epidemiology and Prevention Research.|
|The Physical Object|
|Pagination||iv, 233 p. :|
|Number of Pages||233|
In National Household Survey on Drug Abuse: Methodological resource book (Volume 1, Section 2, prepared for the Substance Abuse and Mental Health Services Administration, Office of Applied Studies, under Contract No. , Deliverable No. 10, Citations: 2 - 0 self. An ounce of prevention, a pound of uncertainty: The cost-effectiveness of school-based drug prevention programs, Santa Monica, CA: Rand. Google Scholar Center for Cited by: Download Cost-benefit-cost-effectiveness-analysis ebook PDF or Read Online books in PDF, EPUB, The examples and applications used throughout the book are directed at educators but can be readily generalized to other professions and services Cost Benefit Cost Effectiveness Research Of Drug Abuse Prevention. Author: William J. Policymakers and other stakeholders can use cost-benefit analysis as an informative tool for decisionmaking for substance abuse prevention. This report .
Cost-Benefit Estimates in Prevention Research Cost-Benefit Estimates in Prevention Research Swisher, John; Scherer, Jennifer; Yin, Robert This paper reviews seven cost-benefit estimates made in prevention studies published in peer-reviewed journal articles or peer-edited book chapters. This paper includes articles that . Finally, this model did not simulate changing drug costs over time and how that would affect the cost-effectiveness of early treatment. Market or political forces may result in significantly decreased drug costs in the next several years, and a subset of patients, given the slow progression of HCV, may be treated at a lower cost without a risk Cited by: Most research in clinical psychology and related disciplines does not measure, report, or analyze costs, cost-effectiveness, or cost-benefit analysis. Reasons for this are discussed. Acquisition Note: GPO Contents: Impact of substance abuse on federal spending -- Historical perspective on effective prevention -- School-based approaches to drug abuse prevention: evidence for effectiveness and suggestions for determining cost-effectiveness -- Effectiveness of prevention interventions with youth at high risk of.
Cost-benefit considerations in preventive intervention: Continued research is needed on the public health impact and cost-effectiveness of school-based prevention programs. Pentz () estimated that for every $1 spent on the Midwestern Prevention Project, $8 in treatment costs was saved for teenagers and $67 in treatment costs for adults. Applies an economic cost analysis to schoolwide positive behavior support and discusses the implications for extending the analysis to cost-effectiveness and cost-benefit models of program success. (Not bound to a specific type or size of school.). Yates consults regularly on a variety of federally funded projects in health, alcohol and drug addiction, media-based substance abuse prevention, mental health services for children and families, and multi-site studies of the costs, benefits, cost-effectiveness, and cost-benefit of adding consumer-operated services to traditional mental health. Prevention Research: Deterring Drug Abuse Among Children and Adolescents, ed. by Catherine S. Bell and Robert Battjes (PDF at NIH) Filed under: Smoking -- United States -- Prevention Reducing Tobacco Use: A Report of the Surgeon General (), by United States Department of Health and Human Services (PDF files at ).